Question 1
What responsibility remains with the investigator when activities are transferred to a service provider?
Correct Answer:
The responsibility for such activities remains with the investigator.
Explanation:
When activities are delegated to a service provider, the investigator still bears the overall responsibility for the conduct of the trial at the site. This means ensuring that protocol procedures are followed, participant rights and safety are protected, informed consent is properly obtained and documented, data are accurately collected and reported, and regulatory obligations are met. The investigator must supervise the service provider, verify the quality of work, and be able to account for all trial activities to sponsors, regulators, and ethics bodies. Delegation is permitted, but accountability does not transfer away from the investigator. The sponsor does not take on all responsibility simply by delegating tasks, and the service provider cannot be solely responsible for the trial’s conduct. The IRB oversees ethical review and ongoing safety monitoring, but it does not manage day-to-day trial execution.
Question 2
When can an investigator deviate from the protocol?
Correct Answer:
Only where necessary to eliminate immediate hazards to trial participants.
Explanation:
The key idea is that participant safety drives any departure from the study plan. An investigator may deviate from the protocol only to eliminate an immediate hazard to trial participants. This allows a rapid, safety-driven action without waiting for formal approvals, but it must be documented and communicated to the sponsor and the ethics committee as soon as feasible, and a formal protocol amendment should be pursued afterward if the change is to be kept. This is why the correct approach is to act only when immediate safety concerns require it. Deviation for convenience or operational reasons isn’t permitted, and it isn’t acceptable to rely on sponsor approval alone to justify a change that could affect safety or data integrity. If a deviation occurs, it should be clearly explained in records, and the sponsor/IRB should be informed so appropriate oversight and potential amendment can follow.
Question 3
What best describes a systemic issue in a trial?
Correct Answer:
A problem that affects multiple processes or the overall trial rather than a single isolated event
Explanation:
A systemic issue is a problem that affects multiple processes or the entire trial, not just a single isolated event. It points to a flaw in the trial’s systems or procedures that can impact data integrity, participant safety, or compliance across sites. For example, a fault in the data capture software used at several sites, or consistent protocol misinterpretation due to insufficient training, would be systemic because it influences the study as a whole. In contrast, problems confined to one site with no wider impact, or a data entry error that happens only once, are isolated incidents and do not indicate a systemic issue. A late ethics approval at a single site is likewise an administrative delay limited in scope; it would become systemic only if it recurred across multiple SAMPLEsites or reflected a broader process failure.
Question 4
What type of access to sponsor data should the investigator have?
Correct Answer:
Timely access to data, including relevant external sources.
Explanation:
Timely access to data is essential for a investigator to effectively monitor safety, protect the rights and welfare of participants, and ensure data integrity throughout the trial. Having access to sponsor data, and including relevant external sources, lets the investigator see all information needed to assess risks, verify findings, and make informed decisions during the study. Delaying access until after the trial ends would prevent prompt safety actions and ongoing oversight. Limiting the view to internal site data excludes important information generated or compiled by the sponsor or external sources that can impact subject safety and trial conclusions. Not having access to external data similarly restricts the ability to evaluate the full context of the trial results.
Question 5
In the consent process, how should the information be conveyed to ensure understanding?
Correct Answer:
Understanding is not required for consent.
Explanation:
Understanding must guide the consent process. Information should be presented in clear, concise language that the participant or their legally authorized representative can understand, and it should be tailored to their language, literacy, and cultural context. This clarity gives the person a real opportunity to grasp what participation involves, ask questions, and consider risks and benefits before agreeing. Merely delivering information at a high, technical level or assuming understanding from literacy alone undermines an individual's ability to decide freely. Informed consent is about comprehension, not just exposure to information, and it’s treated as an ongoing, voluntary choice rather than a one-time form.
Question 1
Exam overview

About this Exam

Prepare with the Good Clinical Practice E6 (R3) Practice Test practice quiz. This question bank includes 10 questions covering investigator, trial, participant, describes, and data. Use it to review important concepts, identify knowledge gaps, and build confidence for the related exam, course, or assessment.

More details

Additional Information

Good Clinical Practice E6 (R3) Practice Test

This practice set contains 10 questions from the matching question bank and focuses on investigator, trial, participant, describes, and data. Work through each question carefully, review the provided solutions, and revisit topics that need more study before your next attempt.

This is an independent study resource intended for practice and review; it is not an official examination or an endorsement by any organization named in the title.

Quiz information

Frequently Asked Questions

The complete question count is available after full access is unlocked.
No fixed duration is currently configured for this quiz.
Question explanations are included where they are available in the quiz content, helping you review the reasoning after answering.
Yes. You can retake the practice test again as you continue studying during your available access period.
After your access is confirmed, you can continue into the complete practice exam from this quiz flow.
Unless explicitly stated otherwise, this page provides independent practice material for study and exam preparation and is not the official examination itself.
Keep studying

Related Questions